For IndividualsFor Educators
ExpertMinds LogoExpertMinds
ExpertMinds

Ace your certifications with Practice Exams and AI assistance.

  • Browse Exams
  • For Educators
  • Blog
  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Support
  • AWS SAA Exam Prep
  • PMI PMP Exam Prep
  • CPA Exam Prep
  • GCP PCA Exam Prep

© 2026 TinyHive Labs. Company number 16262776.

    PracticeACCAACCA FR — Financial Reporting Practice Exam 2Question 32
    Hard20 marksExtended Response
    Preparation of Single Entity Financial StatementsSingle EntityRatio AnalysisIAS 38IAS 12

    ACCA · Question 32 · Preparation of Single Entity Financial Statements

    Section C - Constructed Response 2

    BioPharma Innovations is preparing its financial statements for the year ended 31 December 20X5.

    Draft figures before adjustments ($'000):
    Revenue: 45,000
    Cost of Sales: (22,000)
    Gross Profit: 23,000
    Operating Expenses: (12,000)
    Operating Profit: 11,000
    Finance Costs: (1,000)
    Profit Before Tax: 10,000

    Equity and Liabilities at 31 Dec 20X5 (Draft, $'000):
    Equity: 30,000
    Long-term Loan: 15,000

    Adjustments required:

    1. R&D: Operating expenses include $3,000,000 spent on developing a new drug. Technical and commercial feasibility were established on 1 July 20X5. $1,000,000 of the $3,000,000 was incurred evenly between 1 July and 31 December. The drug is not yet complete, so no amortization is required.
    2. Revaluation: Lab equipment with a carrying amount of $4,000,000 was revalued to $5,500,000 on 31 December 20X5. This has not been recorded.
    3. Taxation: The current tax bill for the year is estimated at $1,800,000. Additionally, the deferred tax liability needs to increase by $400,000 (of which $300,000 relates to the lab equipment revaluation, and $100,000 relates to temporary differences in profit or loss).

    Requirement:
    (a) Prepare the revised Statement of Profit or Loss and Other Comprehensive Income for the year ended 31 December 20X5. (10 marks)
    (b) Calculate the following ratios for 20X5 based on your revised figures:
    i. Operating Profit Margin
    ii. Interest Cover
    iii. Return on Capital Employed (ROCE) (Use closing capital employed). (6 marks)
    (c) Briefly comment on the impact of capitalizing the development costs on the ROCE compared to if they had been fully expensed. (4 marks)

    How to approach this question

    Part A: Adjust operating expenses by removing the eligible development costs. Calculate the tax expense (current + P&L deferred). Calculate OCI (revaluation gain less deferred tax on it). Part B: Use the standard formulas. Remember to update the Equity figure for the new profit and OCI before calculating ROCE. Part C: Explain the mathematical effect of increasing both profit and capital employed by the same amount.

    Full Answer

    .

    Common mistakes

    Putting the deferred tax on the revaluation into the P&L tax expense. Forgetting to update the Capital Employed figure with the adjustments before calculating ROCE.
    Question 31All questions

    Practice the full ACCA FR — Financial Reporting Practice Exam 2

    32 questions · hints · full answers · grading

    Sign up freeTake the exam

    More questions from this exam

    Q01**Section A** GlobalHealth NGO recently changed its accounting policy for valuing medical invent...EasyQ02**Section A** CloudSync, a tech startup, signs a contract to provide a customer with a customize...MediumQ03**Section A** AgriCorp owns a specialized automated harvester purchased for $200,000 on 1 Januar...MediumQ04**Section A** MetroWater, a public utility, operates a water treatment plant with a carrying amo...MediumQ05**Section A** Oceanic Drillers, a cross-border multinational, has a decommissioning provision fo...Hard
    View all 32 questions →